The company has received final ANDA approval for its Pramipexole Dihydrochloride tablets, 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg and 1.5 mg from the USFDA.
Share price of Unichem Laboratories added 4.7 percent in the early trade on Monday after company received ANDA approval from USFDA.
The company has received final ANDA approval for its Pramipexole Dihydrochloride tablets, 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg and 1.5 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Boehringer Ingelheim Pharmaceauticals Inc's Mirapex tablets.
Pramipexole Dihydrochloride tablets are indicated for the treatment of Parkinson's disease and for the treatment of moderate-to- severe primary restless legs syndrome (RLS).
At 09:18 hrs Unichem Laboratories was quoting at Rs 196.80, up Rs 4.70, or 2.45 percent on the BSE.
GET ONE DAY FREE TRIAL>>>GOLD SILVER TIPS
No comments:
Post a Comment